NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/04/2025
Back to search
Official data from USPTO
GLEOSTINE (LOMUSTINE) CAPSULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
10/28/2025
Trademark type
Combined
Nice classes
5
Filing date
04/29/2014
Registration date
07/21/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/26/2015
First use in commerce
01/27/2015
Drawing code
3
Owner type
03
Owner location
WOBURN, MA
Examiner
BURNS, ELLEN
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "Gleostine" with the words "(lomustine) Capsules" below it. Above "stine" in "Gleostine" there are two arcs of about equal dimensions. One arc is in front of the other and they are substantially parallel.
Holders and representatives
Holders
AZURITY PHARMACEUTICALS, INC.
NextSource Biotechnology, LLC
Representatives
Douglas R. Wolf Wolf Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparations containing lomustine; Biological preparations for the treatment of cancer containing lomustine; Pharmaceutical products for the prevention and treatment of cancer containing lomustine
Publications
History of USPTO decisions and trademark events.
56 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/04/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/04/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/04/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
06/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/05/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/28/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/21/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/30/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/30/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/03/2022
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
12/31/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/18/2021
E815
TEAS SECTION 8 & 15 RECEIVED
09/20/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/21/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
05/15/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
05/15/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/14/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/14/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/14/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/14/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/13/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/12/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/31/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/31/2015
IUAF
USE AMENDMENT FILED
04/28/2015
EISU
TEAS STATEMENT OF USE RECEIVED
04/28/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/23/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/28/2014
PUBO
PUBLISHED FOR OPPOSITION
10/28/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/08/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/22/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2014
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/17/2014
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/12/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/26/2014
ALIE
ASSIGNED TO LIE
07/21/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
07/02/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/02/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
07/02/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/02/2014
DOCK
ASSIGNED TO EXAMINER
06/28/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/15/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/14/2014
NWAP
NEW APPLICATION ENTERED
05/02/2014
Continuous trademark protection
Get notified about every new filing that threatens GLEOSTINE (LOMUSTINE) CAPSULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.